Mayo Clinic medical device firm to expand its research offerings
Rochester-based Resoundant, which makes a paddle-like imaging device and software that works with traditional magnetic resonance image scanners to scan organs by using sound waves., is expanding its research services to tap into the expertise of its staff and that of Mayo Clinic.
A Mayo Clinic-owned medical device firm is expanding its clinical research services to tap into the expertise of its team.
Rochester-based Resoundant makes a paddle-like imaging device and software that works with traditional magnetic resonance image scanners to scan organs by using sound waves. It was founded by Resoundant CEO and prominent Mayo Clinic researcher Dr. Richard Ehman .
It is wholly owned by Mayo Clinic and 12 inventors of the process called magnetic resonance elastography.
The company has gained a lot of traction since it launched in the early 2000s. In 2017, it outgrew its space in the Mayo Clinic Business Accelerator and moved into a larger office on the second floor of the Premier Bank Professional Building at 421 First Ave. SW.
While its products are gaining momentum in the imaging market, the company’s knowledge is becoming more sought after for clinical trials and research. That has led to the recent expansion of its services.
These new services include “access to Resoundant/Mayo Clinic analysts for central image reads, secure data management, quantitative reporting, site training and identification, regulatory support, study start-up/close-out support, quality control, and proprietary in-house analytics,” according to an announcement by the firm.
“We’re extremely fortunate to be able to tap the expertise and technical know-how of the team that pioneered the development and translation of MRE at Mayo Clinic,” stated Ehman in a press release. “Our continuing goals are to help move these projects forward at a lower cost and with greater technical capacity than ever before.”
Since 2017, Resoundant and Mayo Clinic staff have consulted or served as a core laboratory on nearly a dozen trials involving liver disease.
“This is a very natural expansion for our company,” stated Chief Operating Officer Kathy Anderson. “Our close connections with Mayo Clinic, as well as with talented contract research organizations across the globe, has resulted in sustained organic growth for our clinical trial services.”
Jeff Kiger tracks business action in Rochester and southeastern Minnesota every day in "Heard on the Street." Send tips to firstname.lastname@example.org or via Twitter to @whereskiger . You can call him at 507-285-7798.